About Anuh Pharma Limited
Data last updated: 22 December 2025
Anuh Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 19 February 1960, the company has been in operation for over 66 years.
Registered with ROC Mumbai under CIN L24230MH1960PLC011586. Listed on BSE: 506260.
Capital: an authorised share capital of ₹51 Cr and a paid-up capital of ₹50.11 Cr. It is led by directors including Siddharth Shah Jasvantlal and Mita Dixit.
Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: A 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹670.97 Cr, a growth of 2% compared to the previous year.
The company has a workforce of approximately 212 employees as per the latest available data.
The company is associated with 2 brands - Anuh Pharma, Sk Age Exports. As per MCA filings, the company has open charges of ₹95.03 Cr and satisfied charges of ₹112.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anuhpharma.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressA 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Anuh Pharma Limited
Anuh Pharma Limited has one previous CIN (Corporate Identification Number): U24230MH1960PLC011586. The current CIN is L24230MH1960PLC011586, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH1960PLC011586 | Current |
| U24230MH1960PLC011586 | Previous |
Associated Brands with Anuh Pharma Limited
Anuh Pharma Limited operates two associated brands: Anuh Pharma and SK Age Exports. These brands represent Anuh Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs, bulk drugs, and formulations are manufactured and traded. | anuhpharma.com | |
| International goods exports are managed from Mumbai, India. | skageexports.com |
Competitors & Alternatives of Anuh Pharma Limited
Brands and companies operating in the same space as Anuh Pharma Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Anuh Pharma Limited
Anuh Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Anuh Pharma Limited
Anuh Pharma Limited is audited by JAYANTILAL THAKKAR & CO. (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| JAYANTILAL THAKKAR & CO. (ICAI peer reviewed, certificate valid till 2027-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Anuh Pharma Limited
Anuh Pharma Limited is currently managed by 14 directors, with 22 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Siddharth Shah Jasvantlal
Also directs:
Amanecer Capital Partners Llp, Aes Trading And Consultants Llp, Anuh Pharma Limited and 2 more
|
Director | 01 Apr 2024 | 2 Years 3 Months | Current |
|
Mita Dixit
Also directs:
Anuh Pharma Limited, Shetron Limited, Hindustan Construction Company Limited and 3 more
|
Director | 08 Feb 2019 | 7 Years 5 Months | Current |
| Samir Jayantilal Shah | Director | 09 Aug 2016 | 9 Years 11 Months | Current |
|
Ritesh Bipin Shah
Also directs:
Anuh Pharma Limited, S Kant Healthcare Limited
|
Managing Director | 09 Aug 2016 | 9 Years 11 Months | Current |
|
Gaurav Satish Shah
Also directs:
Anuh Pharma Limited, S Kant Healthcare Limited, S Kant Chemicals Private Limited and 1 more
|
Director | 01 Jul 2023 | 3 Years 0 Months | Current |
|
Harmanbhai Tulshibhai Patel
Also directs:
Anuh Pharma Limited, Lewens Labs Private Limited
|
Director | 22 May 2019 | 7 Years 1 Months | Current |
Financials of Anuh Pharma Limited FY 2026 filings available
Anuh Pharma Limited reported revenue of ₹771.66 Cr (up 16.65% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹771.66 Cr | ₹661.51 Cr |
| Other Income | ₹4.36 Cr | ₹9.46 Cr |
| Total Income | ₹776.01 Cr | ₹670.97 Cr |
| Cost of Materials Consumed | ₹510.44 Cr | ₹463.28 Cr |
| Purchases of Stock-in-Trade | ₹79.2 Cr | ₹38.55 Cr |
| Changes in Inventories | ₹10.02 Cr | -₹2.45 Cr |
| Employee Benefit Expense | ₹26.3 Cr | ₹23.04 Cr |
| Finance Costs | ₹47.23 Lakh | ₹61.93 Lakh |
| Depreciation & Amortisation | ₹11.38 Cr | ₹8.74 Cr |
| Other Expenses | ₹83.97 Cr | ₹78.2 Cr |
| Total Expenses | ₹721.79 Cr | ₹609.96 Cr |
| Profit Before Exceptional Items & Tax | ₹54.22 Cr | ₹61.01 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹54.22 Cr | ₹61.01 Cr |
| Total Tax Expense | ₹13.18 Cr | ₹13.65 Cr |
| Net Profit | ₹41.05 Cr | ₹47.35 Cr |
| Other Comprehensive Income | ₹18.51 Lakh | -₹1.7 Lakh |
| Total Comprehensive Income | ₹41.23 Cr | ₹47.33 Cr |
| EBITDA (computed) | ₹66.08 Cr | ₹70.36 Cr |
| Basic EPS | ₹4.10 | ₹9.45 |
| Diluted EPS | ₹4.10 | ₹9.45 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹557.37 Cr | ₹506.63 Cr |
| Non-current Assets | ₹106.05 Cr | ₹130.46 Cr |
| Current Assets | ₹451.32 Cr | ₹376.17 Cr |
| Property, Plant & Equipment | ₹47.99 Cr | ₹49.58 Cr |
| Inventories | ₹147.76 Cr | ₹74.48 Cr |
| Trade Receivables | ₹238.63 Cr | ₹215.87 Cr |
| Cash & Equivalents | ₹8.06 Cr | ₹19.56 Cr |
| Equity (Net Worth) | ₹352.22 Cr | ₹326.02 Cr |
| Equity Share Capital | ₹50.11 Cr | ₹25.06 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹10.5 Cr |
| Total Debt (computed) | ₹0 | ₹10.5 Cr |
| Current Liabilities | ₹203 Cr | ₹178.51 Cr |
| Total Liabilities | ₹205.15 Cr | ₹180.6 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | -₹3.01 Cr | ₹37.12 Cr |
| Investing Cash Flow | ₹17.84 Cr | -₹19.91 Cr |
| Financing Cash Flow | -₹26.33 Cr | -₹4.86 Cr |
| Capital Expenditure | ₹7.87 Cr | ₹19.96 Cr |
| Free Cash Flow (computed) | -₹10.88 Cr | ₹17.16 Cr |
| Dividends Paid | ₹14.97 Cr | ₹12.52 Cr |
| Net Change in Cash | -₹11.5 Cr | ₹12.36 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹202.12 Cr | ₹197.18 Cr | ₹185.88 Cr | ₹186.48 Cr | ₹198.14 Cr | ₹159.51 Cr |
| Other Income | -₹1.25 Cr | ₹4.11 Cr | ₹97.85 Lakh | ₹3.39 Cr | ₹1.4 Cr | ₹93.76 Lakh |
| Total Income | ₹200.86 Cr | ₹201.29 Cr | ₹186.86 Cr | ₹189.87 Cr | ₹199.54 Cr | ₹160.45 Cr |
| Cost of Materials Consumed | ₹140.71 Cr | ₹114.31 Cr | ₹131.51 Cr | ₹123.91 Cr | ₹137.92 Cr | ₹118.65 Cr |
| Purchases of Stock-in-Trade | ₹2.83 Cr | ₹31.48 Cr | ₹18.39 Cr | ₹26.5 Cr | ₹10.93 Cr | ₹14.55 Cr |
| Changes in Inventories | ₹7.68 Cr | ₹5.48 Cr | -₹5.37 Cr | ₹2.22 Cr | -₹38.3 Lakh | -₹12.73 Cr |
| Employee Benefit Expense | ₹6.35 Cr | ₹6.91 Cr | ₹6.75 Cr | ₹6.3 Cr | ₹6.85 Cr | ₹5.54 Cr |
| Finance Costs | ₹10.58 Lakh | ₹7.96 Lakh | ₹7.56 Lakh | ₹21.13 Lakh | ₹3.35 Lakh | ₹28.03 Lakh |
| Depreciation & Amortisation | ₹3 Cr | ₹3 Cr | ₹2.86 Cr | ₹2.52 Cr | ₹2.76 Cr | ₹2.18 Cr |
| Other Expenses | ₹24.66 Cr | ₹22.19 Cr | ₹22.72 Cr | ₹17.27 Cr | ₹24.16 Cr | ₹18.71 Cr |
| Total Expenses | ₹185.34 Cr | ₹183.46 Cr | ₹176.94 Cr | ₹178.91 Cr | ₹182.26 Cr | ₹147.19 Cr |
| Profit Before Exceptional Items & Tax | ₹15.52 Cr | ₹17.83 Cr | ₹9.92 Cr | ₹10.95 Cr | ₹17.28 Cr | ₹13.27 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹15.52 Cr | ₹17.83 Cr | ₹9.92 Cr | ₹10.95 Cr | ₹17.28 Cr | ₹13.27 Cr |
| Total Tax Expense | ₹3.84 Cr | ₹4.38 Cr | ₹2.31 Cr | ₹2.65 Cr | ₹4.82 Cr | ₹2.92 Cr |
| Net Profit | ₹11.68 Cr | ₹13.45 Cr | ₹7.61 Cr | ₹8.3 Cr | ₹12.46 Cr | ₹10.34 Cr |
| Other Comprehensive Income | -₹29.34 Lakh | ₹45.55 Lakh | ₹8.37 Lakh | -₹6.07 Lakh | ₹10.27 Lakh | ₹77,000 |
| Total Comprehensive Income | ₹11.39 Cr | ₹13.91 Cr | ₹7.7 Cr | ₹8.24 Cr | ₹12.56 Cr | ₹10.35 Cr |
| EBITDA (computed) | ₹18.63 Cr | ₹20.91 Cr | ₹12.86 Cr | ₹13.68 Cr | ₹20.07 Cr | ₹15.73 Cr |
| Basic EPS | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 | ₹2.49 | ₹2.06 |
| Diluted EPS | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 | ₹2.49 | ₹2.06 |
Shareholding Pattern of Anuh Pharma Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 71.80%, foreign institutional investors hold 0.05%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 28.16% of Anuh Pharma Limited. The company had 27,425 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 71.80% | 71.82% | 71.82% | 69.92% | 69.92% | 69.92% |
| Public | 28.20% | 28.18% | 28.18% | 30.08% | 30.08% | 30.08% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 71.80% | 69.92% |
| Public | 28.20% | 30.08% |
| Promoter change (YoY, %pts) | +1.88 | - |
Board & Governance of Anuh Pharma Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Anuh Pharma Limited has 12 directors - 4 independent and 2 executive. The board is chaired by Arun Lalchand Todarwal.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Arun Lalchand Todarwal | Non-Executive - Non Independent Director · Chairperson | 2014-04-01 | 4 |
| Bipin Nemchand Shah | Non-Executive - Non Independent Director | 2009-04-01 | 1 |
| Bharat Nemchand Shah | Non-Executive - Non Independent Director | 1980-10-29 | 1 |
| Samir Jayantilal Shah | Non-Executive - Non Independent Director | 2016-08-09 | 1 |
| Ketan Lalitkumar Shah | Non-Executive - Non Independent Director | 2016-08-09 | 1 |
| Ritesh Bipin Shah | Executive Director · MD | 2016-08-09 | 1 |
| Vivek Bipin Shah | Executive Director · MD | 2016-08-09 | 1 |
| Mita Chittaranjan Dixit | Non-Executive - Independent Director | 2019-02-08 | 3 |
| Harmanbhai Tulshibhai Patel | Non-Executive - Independent Director | 2019-05-22 | 1 |
| Gaurav Satish Shah | Non-Executive - Non Independent Director | 2023-07-01 | 1 |
| Siddharth Jasvantlal Shah | Non-Executive - Independent Director | 2024-04-01 | 1 |
| Pradeep Hari Thakur | Non-Executive - Independent Director | 2024-04-01 | 3 |
| Committee | Members |
|---|---|
| Audit Committee | Harmanbhai Tulshibhai Patel (Chairperson), Bipin Nemchand Shah, Arun Lalchand Todarwal, Siddharth Jasvantlal Shah, Pradeep Hari Thakur, Mita Chittaranjan Dixit |
| Nomination and remuneration committee | Mita Chittaranjan Dixit (Chairperson), Arun Lalchand Todarwal, Harmanbhai Tulshibhai Patel, Siddharth Jasvantlal Shah |
| Stakeholders Relationship Committee | Bharat Nemchand Shah (Chairperson), Bipin Nemchand Shah, Ketan Lalitkumar Shah, Siddharth Jasvantlal Shah |
| Corporate Social Responsibility Committee | Siddharth Jasvantlal Shah (Chairperson), Bipin Nemchand Shah, Arun Lalchand Todarwal |
Charges & Borrowings of Anuh Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2017 | Hdfc Bank Limited | ₹95 Cr | Open |
| 08 Jan 1987 | Canara Bank | ₹3 Lakh | Open |
| 06 Jan 2007 | Bank of India | ₹65 Cr | Satisfied |
| 20 Mar 1999 | Bank of India | ₹25 Lakh | Satisfied |
| 23 Apr 1997 | Bank of India | ₹20 Lakh | Satisfied |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Anuh Pharma Limited
Anuh Pharma Limited has a workforce of 212 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Anuh Pharma Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Anuh Pharma Limited
GSTIN & GST Filing Data of Anuh Pharma Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Anuh Pharma Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Anuh Pharma Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Anuh Pharma Limited
MSME Payment Delays by Anuh Pharma Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Anuh Pharma Limited
Subsidiaries & Group Companies of Anuh Pharma Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Anuh Pharma Limited with ownership details.
MCA Filings & Documents of Anuh Pharma Limited
MCA Filings & Documents of Anuh Pharma Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Anuh Pharma Limited
Recent News on Anuh Pharma Limited
Frequently Asked Questions about Anuh Pharma Limited
Anuh Pharma Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 19 February 1960 (66+ years old) and is registered under CIN L24230MH1960PLC011586. Listed on BSE: 506260. The company has 212 employees.
Anuh Pharma Limited reported revenue of ₹670.97 Cr for FY 2025 (up 2.00% YoY).
The current directors of Anuh Pharma Limited are:
- Siddharth Shah Jasvantlal
- Mita Dixit
- Samir Jayantilal Shah
- Ritesh Bipin Shah
- Vivek Bipin Shah
- Gaurav Satish Shah
- Harmanbhai Tulshibhai Patel
- Arun Todarwal Lalchand
- Pradeep Hari Thakur
- Ketan Lalit Shah
- Darshan Rampariya
- Bipin Nemchand Shah
- Bharat Nemchand Shah
- Manan Jayesh Vadhan
The primary industry of Anuh Pharma Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Anuh Pharma Limited is listed on BSE with code 506260.
Anuh Pharma Limited can be reached at the registered office: A 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018, or through the website anuhpharma.com.